Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality

Srjdan Prodanovich, Robert Kirsner, Jeffrey D. Kravetz, Fangchao Ma, Lisa Martinez, Daniel G. Federman

Research output: Contribution to journalArticle

275 Citations (Scopus)

Abstract

Objective: To examine the cardiovascular risk factors in patients with psoriasis and the association between psoriasis and coronary artery, cerebrovascular, and peripheral vascular diseases. Design: Observational study. Setting: Large Department of Veterans Affairs hospital. Patients: The study included 3236 patients with psoriasis and 2500 patients without psoriasis (controls). Main Outcome Measures: Using International Classification of Diseases, Ninth Revision, Clinical Modification, codes, we compared the prevalence of traditional cardiovascular risk factors and other vascular diseases as well as mortality between patients with psoriasis and controls. Results: Similar to previous studies, we found a higher prevalence of diabetes mellitus, hypertension, dyslipidemia, and smoking in patients with psoriasis. After controlling for these variables, we found a higher prevalence not only of ischemic heart disease (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.51-2.11) but also of cerebrovascular (OR, 1.70; 95% CI, 1.33-2.17) and peripheral vascular (OR, 1.98; 95% CI, 1.32-2.82) diseases in patients with psoriasis compared with controls. Psoriasis was also found to be an independent risk factor for mortality (OR, 1.86; 95% CI, 1.56-2.21). Conclusions: Psoriasis is associated with atherosclerosis. This association applies to coronary artery, cerebrovascular, and peripheral vascular diseases and results in increased mortality.

Original languageEnglish
Pages (from-to)700-703
Number of pages4
JournalArchives of Dermatology
Volume145
Issue number6
DOIs
StatePublished - Jun 1 2009

Fingerprint

Peripheral Vascular Diseases
Psoriasis
Coronary Vessels
Mortality
Odds Ratio
Confidence Intervals
Veterans Hospitals
International Classification of Diseases
Dyslipidemias
Vascular Diseases
Observational Studies
Myocardial Ischemia
Blood Vessels
Atherosclerosis
Diabetes Mellitus
Smoking
Outcome Assessment (Health Care)
Hypertension

ASJC Scopus subject areas

  • Dermatology

Cite this

Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. / Prodanovich, Srjdan; Kirsner, Robert; Kravetz, Jeffrey D.; Ma, Fangchao; Martinez, Lisa; Federman, Daniel G.

In: Archives of Dermatology, Vol. 145, No. 6, 01.06.2009, p. 700-703.

Research output: Contribution to journalArticle

Prodanovich, Srjdan ; Kirsner, Robert ; Kravetz, Jeffrey D. ; Ma, Fangchao ; Martinez, Lisa ; Federman, Daniel G. / Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. In: Archives of Dermatology. 2009 ; Vol. 145, No. 6. pp. 700-703.
@article{cc4019bcc1164e28ae4a5aca5d46c498,
title = "Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality",
abstract = "Objective: To examine the cardiovascular risk factors in patients with psoriasis and the association between psoriasis and coronary artery, cerebrovascular, and peripheral vascular diseases. Design: Observational study. Setting: Large Department of Veterans Affairs hospital. Patients: The study included 3236 patients with psoriasis and 2500 patients without psoriasis (controls). Main Outcome Measures: Using International Classification of Diseases, Ninth Revision, Clinical Modification, codes, we compared the prevalence of traditional cardiovascular risk factors and other vascular diseases as well as mortality between patients with psoriasis and controls. Results: Similar to previous studies, we found a higher prevalence of diabetes mellitus, hypertension, dyslipidemia, and smoking in patients with psoriasis. After controlling for these variables, we found a higher prevalence not only of ischemic heart disease (odds ratio [OR], 1.78; 95{\%} confidence interval [CI], 1.51-2.11) but also of cerebrovascular (OR, 1.70; 95{\%} CI, 1.33-2.17) and peripheral vascular (OR, 1.98; 95{\%} CI, 1.32-2.82) diseases in patients with psoriasis compared with controls. Psoriasis was also found to be an independent risk factor for mortality (OR, 1.86; 95{\%} CI, 1.56-2.21). Conclusions: Psoriasis is associated with atherosclerosis. This association applies to coronary artery, cerebrovascular, and peripheral vascular diseases and results in increased mortality.",
author = "Srjdan Prodanovich and Robert Kirsner and Kravetz, {Jeffrey D.} and Fangchao Ma and Lisa Martinez and Federman, {Daniel G.}",
year = "2009",
month = "6",
day = "1",
doi = "10.1001/archdermatol.2009.94",
language = "English",
volume = "145",
pages = "700--703",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality

AU - Prodanovich, Srjdan

AU - Kirsner, Robert

AU - Kravetz, Jeffrey D.

AU - Ma, Fangchao

AU - Martinez, Lisa

AU - Federman, Daniel G.

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Objective: To examine the cardiovascular risk factors in patients with psoriasis and the association between psoriasis and coronary artery, cerebrovascular, and peripheral vascular diseases. Design: Observational study. Setting: Large Department of Veterans Affairs hospital. Patients: The study included 3236 patients with psoriasis and 2500 patients without psoriasis (controls). Main Outcome Measures: Using International Classification of Diseases, Ninth Revision, Clinical Modification, codes, we compared the prevalence of traditional cardiovascular risk factors and other vascular diseases as well as mortality between patients with psoriasis and controls. Results: Similar to previous studies, we found a higher prevalence of diabetes mellitus, hypertension, dyslipidemia, and smoking in patients with psoriasis. After controlling for these variables, we found a higher prevalence not only of ischemic heart disease (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.51-2.11) but also of cerebrovascular (OR, 1.70; 95% CI, 1.33-2.17) and peripheral vascular (OR, 1.98; 95% CI, 1.32-2.82) diseases in patients with psoriasis compared with controls. Psoriasis was also found to be an independent risk factor for mortality (OR, 1.86; 95% CI, 1.56-2.21). Conclusions: Psoriasis is associated with atherosclerosis. This association applies to coronary artery, cerebrovascular, and peripheral vascular diseases and results in increased mortality.

AB - Objective: To examine the cardiovascular risk factors in patients with psoriasis and the association between psoriasis and coronary artery, cerebrovascular, and peripheral vascular diseases. Design: Observational study. Setting: Large Department of Veterans Affairs hospital. Patients: The study included 3236 patients with psoriasis and 2500 patients without psoriasis (controls). Main Outcome Measures: Using International Classification of Diseases, Ninth Revision, Clinical Modification, codes, we compared the prevalence of traditional cardiovascular risk factors and other vascular diseases as well as mortality between patients with psoriasis and controls. Results: Similar to previous studies, we found a higher prevalence of diabetes mellitus, hypertension, dyslipidemia, and smoking in patients with psoriasis. After controlling for these variables, we found a higher prevalence not only of ischemic heart disease (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.51-2.11) but also of cerebrovascular (OR, 1.70; 95% CI, 1.33-2.17) and peripheral vascular (OR, 1.98; 95% CI, 1.32-2.82) diseases in patients with psoriasis compared with controls. Psoriasis was also found to be an independent risk factor for mortality (OR, 1.86; 95% CI, 1.56-2.21). Conclusions: Psoriasis is associated with atherosclerosis. This association applies to coronary artery, cerebrovascular, and peripheral vascular diseases and results in increased mortality.

UR - http://www.scopus.com/inward/record.url?scp=67449110958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67449110958&partnerID=8YFLogxK

U2 - 10.1001/archdermatol.2009.94

DO - 10.1001/archdermatol.2009.94

M3 - Article

C2 - 19528427

AN - SCOPUS:67449110958

VL - 145

SP - 700

EP - 703

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 6

ER -